Endurant Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-44,384
Closed -$4.57M 42
2023
Q3
$4.57M Sell
44,384
-4,948
-10% -$533K 4.1% 7
2023
Q2
$5.69M Sell
49,332
-241
-0.5% -$27.4K 4.97% 5
2023
Q1
$5.27M Sell
49,573
-76,430
-61% -$8.25M 2.71% 12
2022
Q4
$14M Buy
+126,003
New +$12.9M 5.68% 4
2021
Q1
Sell
-15,635
Closed -$1.22M 67
2020
Q4
$1.22M Buy
+15,635
New +$1.2M 0.44% 45
2018
Q4
Sell
-83,937
Closed -$5.68M 67
2018
Q3
$5.68M Sell
83,937
-186,524
-69% -$11.9M 2.53% 11
2018
Q2
$15.7M Buy
270,461
+89,471
+49% +$5.05M 6.79% 2
2018
Q1
$9.41M Buy
180,990
+69,797
+63% +$3.77M 3.51% 10
2017
Q4
$5.97M Buy
+111,193
New +$6.16M 1.82% 22
2016
Q4
Sell
-5,345
Closed -$318K 82
2016
Q3
$318K Buy
+5,345
New +$313K 0.12% 87
2016
Q2
Sell
-10,590
Closed -$535K 94
2016
Q1
$535K Sell
10,590
-38,147
-78% -$1.87M 0.17% 66
2015
Q4
$2.46M Sell
48,737
-203,207
-81% -$10.2M 0.82% 40
2015
Q3
$11.9M Buy
251,944
+39,928
+19% +$2.12M 3.96% 6
2015
Q2
$11.5M Buy
212,016
+167,156
+373% +$9.37M 3.4% 8
2015
Q1
$2.46M Buy
44,860
+1,887
+4% +$107K 0.81% 46
2014
Q4
$2.33M Buy
+42,973
New +$2.39M 0.91% 37

Other funds holding MRK

Endurant Capital Management's MRK Position: Q4 2023 in Review

Endurant Capital Management sold out of Merck (MRK) in Q4 2023, closing a stake of 44,384 shares — an estimated $4.57M sold.

Endurant Capital Management first reported a position in MRK in Q4 2014 and held it in 16 quarters. The position peaked at $15.7M in Q2 2018. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Endurant Capital Management reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Endurant Capital Management sold 44,384 Merck shares in Q4 2023, an estimated $4.57M.
  • Endurant Capital Management first reported a position in Merck in Q4 2014 and held it in 16 quarters.
  • Endurant Capital Management's Merck position peaked at $15.7M in Q2 2018.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.